---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40094966.md"
description: "Merck still faces pressure ahead of the earnings season, with competition in the GLP-1 space weighing on valuations; WuXi Biologics continues to be concerned about the risk of foreign capital withdrawal; Moderna still has support from seasonal demand; two Hong Kong-listed biotech companies, GenScript and YAOJIE ANKANG, each have their own catalysts."
datetime: "2026-04-22T10:38:11.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40094966.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40094966.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40094966.md)
author: "[ Timmy](https://longbridge.com/en/profiles/27514737.md)"
---

# Merck still faces pressure ahead of the earnings s…


### Related Stocks

- [01548.HK](https://longbridge.com/en/quote/01548.HK.md)
- [02617.HK](https://longbridge.com/en/quote/02617.HK.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [02269.HK](https://longbridge.com/en/quote/02269.HK.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [WXXWY.US](https://longbridge.com/en/quote/WXXWY.US.md)